186 related articles for article (PubMed ID: 30840061)
1. Neuronal autoantibodies associated with cognitive impairment in melanoma patients.
Bartels F; Strönisch T; Farmer K; Rentzsch K; Kiecker F; Finke C
Ann Oncol; 2019 May; 30(5):823-829. PubMed ID: 30840061
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
Finke C; Bartels F; Lütt A; Prüss H; Harms L
J Neurol; 2017 Sep; 264(9):1968-1977. PubMed ID: 28785798
[TBL] [Abstract][Full Text] [Related]
3. Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
Bartels F; Wandrey MM; Aigner A; Strönisch T; Farmer K; Rentzsch K; Tessmer A; Grohé C; Finke C
JAMA Oncol; 2021 Sep; 7(9):1302-1310. PubMed ID: 34196651
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
5. Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice.
Yue W; Caldwell S; Risbrough V; Powell S; Zhou X
PLoS One; 2021; 16(9):e0256972. PubMed ID: 34473764
[TBL] [Abstract][Full Text] [Related]
6. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis.
Westman G; Sohrabian A; Aurelius E; Ahlm C; Schliamser S; Sund F; Studahl M; Rönnelid J
J Clin Virol; 2018 Jun; 103():75-80. PubMed ID: 29698873
[TBL] [Abstract][Full Text] [Related]
8. Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis.
Abe K; Chiba Y; Katsuse O; Takahashi Y; Suda A; Hattori S; Yoshimi R; Kirino Y; Kunii M; Yoshimi A; Asami T; Hishimoto A
Neurosci Lett; 2021 Jan; 743():135588. PubMed ID: 33359543
[TBL] [Abstract][Full Text] [Related]
9. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
10. Serum and CSF Anti-NMDAR Antibody Testing in Psychiatry.
Warren N; Swayne A; Siskind D; O'Gorman C; Prain K; Gillis D; Blum S
J Neuropsychiatry Clin Neurosci; 2020; 32(2):154-160. PubMed ID: 31530118
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias.
Busse S; Brix B; Kunschmann R; Bogerts B; Stoecker W; Busse M
Neurosci Res; 2014 Aug; 85():58-64. PubMed ID: 24973618
[TBL] [Abstract][Full Text] [Related]
12. Coexisting neuronal autoantibodies among children with demyelinating syndromes.
Kıztanır H; Bektaş G; Yıldız EP; Uzunhan TA; Tatlı B; Aydınlı N; Çalışkan M; Özmen M
Brain Dev; 2017 Mar; 39(3):248-251. PubMed ID: 27823947
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus.
Yue R; Gurung I; Long XX; Xian JY; Peng XB
Lupus; 2020 Nov; 29(13):1743-1751. PubMed ID: 32938321
[TBL] [Abstract][Full Text] [Related]
14. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
Zekeridou A; McKeon A; Lennon VA
JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
[TBL] [Abstract][Full Text] [Related]
16. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
17. A combination of multiple autoantibodies is associated with the risk of Alzheimer's disease and cognitive impairment.
Shim SM; Koh YH; Kim JH; Jeon JP
Sci Rep; 2022 Jan; 12(1):1312. PubMed ID: 35079008
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
Pearlman DM; Najjar S
Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characterization of Definite Autoimmune Limbic Encephalitis: A 30-case Series.
Shojima Y; Nishioka K; Watanabe M; Jo T; Tanaka K; Takashima H; Noda K; Okuma Y; Urabe T; Yokoyama K; Hattori N
Intern Med; 2019 Dec; 58(23):3369-3378. PubMed ID: 31434821
[TBL] [Abstract][Full Text] [Related]
20. The significance of anti-neuronal antibodies for acute psychiatric disorders: a retrospective case-controlled study.
Schou MB; Sæther SG; Drange OK; Krane-Gartiser K; Reitan SK; Vaaler AE; Kondziella D
BMC Neurosci; 2018 Nov; 19(1):68. PubMed ID: 30390633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
